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INTRODUCTION

P arathyroid gland malignancies
are rare, the most common of
which is primary parathyroid
carcinoma.
There are only a few reports of
metastatic breast cancer found in
functioning parathyroid adenomas
Literature suggests a predilection
for tumors to spread to endocrine
organs possibly due to the
plentiful blood supply.
Based on autopsy studies,
metastatic involvement of the
parathyroid gland among known
cancer patients is
0.2-11.9%.
We present the unique case of a
patient presenting with primary
hyperparathyroidism, which
ultimately lead to a diagnosis of
stage IV breast cancer.
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ABSTRACT

A 77-year-old female was referred to endocrinology for hypercalcemia.
Her calcium level was elevated at 10.5 mg/dL (normal 8.5-10.1 mg/dL) with an intact
PTH of 171.3 pg/mL (normal 14.0-72.0 pg/mL), consistent with primary hyperparathyroidism.
She was symptomatic with polyuria, polydipsia, constipation, weakness, and recent 25 lb.
weight loss that she attributed to decreased appetite.
The patient denied taking calcium supplements, personal history of kidney stones, or
family history of MEN syndromes.
Her BMI was 23 kg/m2 and her physical exam was otherwise unremarkable.
Renal ultrasound was negative for nephrolithiasis.
DEXA scan confirmed osteoporosis of the left femoral neck (T score -3.5), and left
forearm (T score -5.4) as well as osteopenia of the lumber spine (T score -1.8).
A Sestamibi scan noted persistent focal activity localizing to a 1.3 x 1.2cm soft tissue
density nodule posterior to right thyroid lobe, consistent with a parathyroid adenoma.
She underwent a right superior and inferior parathyroidectomy based on intraoperative
appearance of the glands. Her post-operative calcium level 8.7 mg/dL (normal 8.5-10.1
mg/dL) and PTH level 118 pg/mL (normal 18.5 - 88.0 pg/mL). Her PTH normalized to
59.4 pg/mL within 4 months.
Pathology report detailed the right inferior parathyroid gland was normocellular
parathyroid tissue, however the right superior parathyroid gland, weighing 1030mg,
revealed hypercellular parathyroid tissue with a 0.5cm deposit of metastatic carcinoma
consistent with breast primary.
Breast exam showed no abnormalities. Mammogram was negative for breast malignancy.
Subsequently, PET scan revealed metabolically active metastases throughout pleura,
thorax, chest wall, bones, and right colon.
The patient was diagnosed with stage IV hormone receptor positive and Her-2/neu
negative breast cancer. She is currently being treated with tamoxifen.

NM PARATHYROID
SPECT
IMPRESSION:

SPECT demonstrates a 1.3 x
1.2 cm nodule posterior to the
right thyroid lobe, consistent with
a parathyroid adenoma.

DEXA SCAN

CONCLUSION

T his case represents a rare presentation of a patient who underwent
surgery for primary hyperparathyroidism and ultimately was diagnosed
with metastatic breast cancer first noted in the parathyroid adenoma.
Few case reports in the literature have described known breast cancer
with spread to the parathyroid gland.

PET CT SCAN
IMPRESSION:

1. M
 etabolically active metastases
with findings suspicious for left
pleural metastases with a
moderate-sized left pleural
effusion. Hypermetabolic nodal
disease in the thorax (hilum and
mediastinum) concerning for
nodal metastases. Multifocal left
chest wall metastases. Possible
osseous metastasis with focal
metabolic activity involving left scapula.
2. M
 ultiple areas of metabolic activity in the right colon with wall
thickening on CT images, colonoscopy is suggested to exclude
underlying colonic polyps/malignancy.
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